What is the recommended method to transition a patient on Humulin 70/30 (insulin human 70 % NPH, 30 % regular) who takes a total of 40 units daily (20 units before breakfast and 20 units before dinner) to insulin glargine, including basal dose calculation and replacement of the regular‑insulin component with separate mealtime insulin?

Transitioning from Humulin 70/30 to Insulin Glargine

When converting a patient from Humulin 70/30 (40 units total daily: 20 units pre-breakfast, 20 units pre-dinner) to insulin glargine, calculate the basal component as 80% of the total NPH dose (approximately 28 units of NPH from the 40 units total), then reduce this by 20% to get 22-24 units of glargine once daily, and add 4 units of rapid-acting insulin before each of the two main meals to replace the regular insulin component. 1

Step-by-Step Conversion Algorithm

1. Calculate the Basal Insulin Dose

The 2025 ADA Standards provide clear guidance for this conversion 1:

• Humulin 70/30 contains 70% NPH (basal) and 30% regular (prandial) insulin 2
• From 40 units total daily dose: approximately 28 units is NPH component
• When converting from twice-daily NPH to once-daily glargine: reduce the total NPH dose by 20% 1
• Calculation: 28 units × 0.80 = 22-24 units of glargine once daily

This 20% reduction is critical because research demonstrates that unit-per-unit conversion from twice-daily NPH to glargine without dose reduction increases hypoglycemia risk 3, 4. The evidence consistently shows that glargine has a flatter, more prolonged pharmacokinetic profile than NPH, making dose reduction necessary for safety 4, 5.

2. Replace the Prandial Component

The regular insulin component (30% of 40 units = 12 units daily) must be replaced with separate mealtime insulin 1:

• Add 4 units of rapid-acting insulin (lispro, aspart, or glulisine) before breakfast
• Add 4 units of rapid-acting insulin before dinner
• This provides 8 units total prandial coverage initially (the remaining 4 units accounts for the dose reduction strategy)

The ADA guidelines specifically recommend starting with "4 units per day or 10% of basal insulin dose" when initiating prandial insulin 1.

3. Timing of Administration

• Glargine: Once daily at bedtime OR at dinnertime (both equally effective) 5
• Rapid-acting insulin: 15 minutes before meals (unlike the 30-45 minutes required for Humulin 70/30) 2

Research shows no difference in glycemic control whether glargine is given at dinner or bedtime 5, providing flexibility for patient preference.

4. Initial Titration Strategy

Following conversion, implement this evidence-based titration 1:

• Set fasting plasma glucose goal (typically 80-130 mg/dL for most patients)
• Increase glargine by 2 units every 3 days until fasting glucose reaches target
• Adjust prandial insulin by 1-2 units or 10-15% based on pre-meal and 2-hour post-meal glucose values
• For hypoglycemia (glucose <70 mg/dL): reduce the corresponding insulin dose by 10-20%

5. Special Considerations and Pitfalls

Critical safety points:

• If A1C <8% at baseline: Consider reducing the basal dose by an additional 4 units (10%) to minimize hypoglycemia risk 1
• Monitor closely for the first 2-4 weeks: Hypoglycemia risk is highest during this period 4
• Do NOT mix glargine with any other insulin 2
• Glargine cannot be used in insulin pumps 2

Common pitfall: Converting unit-per-unit without the 20% reduction leads to excessive basal insulin and increased nocturnal hypoglycemia. The evidence from multiple trials demonstrates that glargine's superior pharmacokinetic profile (24-hour duration, no peak) requires less total basal insulin than twice-daily NPH for equivalent glycemic control 3, 4, 5.

Expected Outcomes

Based on the evidence, this conversion should result in 4, 5, 6:

• Similar or improved HbA1c control (often 0.2-0.4% reduction)
• Reduced hypoglycemia frequency, particularly nocturnal episodes
• More stable fasting glucose levels
• Simplified regimen (fewer injections if patient was on twice-daily 70/30)

Monitoring Requirements

• Daily fasting glucose for first 2 weeks
• Pre-meal and 2-hour post-meal glucose 3-4 times weekly initially
• Follow-up within 1-2 weeks for dose adjustments
• Reassess at 3 months with HbA1c

The advantage of separating basal and prandial insulin is the ability to independently adjust each component based on glucose patterns—something impossible with the fixed-ratio 70/30 formulation 2.